La chaîne d'options affiche les données clés des options sur actions de GoodRx Holdings à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour GoodRx Holdings..

GoodRx Holdings (NASDAQ:GDRX) Stock, Chaîne d'Options

GoodRx Holdings

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

GoodRx Holdings, Inc. - Class A Common Stock

GoodRx Holdings Inc

WIIM

Workiva shares are trading higher following a Q4 revenue beat and issued FY25 revenue guidance above estimates. Also, Citigroup raised its price target on the stock from $128 to $130.

WeRide shares are trading higher after the company launched its GXR Robotaxi full driverless commercial service in Beijing.

Ziff Davis shares are trading lower after multiple firms cut their respective price targets on the stock.

<p>UBS  analyst Kunal Madhukar   maintains ZipRecruiter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>) with a Neutral and lowers the price target from $11 to $7.</p>


News

Price Target

Analyst Ratings

UBS Maintains Neutral on ZipRecruiter, Lowers Price Target to $7

<p>UBS  analyst Chris Kuntarich   maintains Ziff Davis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZD#NASDAQ">ZD</a>) with a Neutral and lowers the price target from $65 to $56.</p>


UBS Maintains Neutral on Ziff Davis, Lowers Price Target to $56

<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.</p>
<ul>
<li>Truist Securities analyst Barry Jonas initiated coverage on <strong>Flutter Entertainment plc</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLUT#NYSE">FLUT</a>) with a Buy rating and announced a price target of $330. Flutter Entertainment shares closed at $260.49 on Tuesday. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Guggenheim analyst Curry Baker initiated coverage on <strong>Sportradar Group AG</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRAD#NASDAQ">SRAD</a>) with a Buy rating and announced a price target of $27. Sportradar shares closed at $20.56 on Tuesday. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>

<p><strong>Considering buying FLUT stock? Here&#8217;s what analysts think: </strong></p>
<p><strong>Read This Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43981181/nvidia-gears-up-for-q4-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts">Nvidia Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></strong></li>
</ul>


Initiation

Markets

Trading Ideas

FLUT

INTU

SRAD

This Flutter Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Wednesday

Macro Economic Events

Global

Economics

SCCO

Citi Says Earlier Duties On Copper Imports Can Also Emerge Via Reciprocal Tariffs (Q2 2025 In Its Base Case)

<p>UBS  analyst Jon Windham   maintains Shoals Technologies Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>) with a Buy and lowers the price target from $8 to $7.</p>


SHLS

UBS Maintains Buy on Shoals Technologies Gr, Lowers Price Target to $7

Citi Says Its Base Case Now Sees A 25% Copper-Specific Tariff Imposed In Q4 2025

<p>UBS  analyst Kunal Madhukar   maintains RealReal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REAL#NASDAQ">REAL</a>) with a Neutral and lowers the price target from $10 to $9.</p>


REAL

UBS Maintains Neutral on RealReal, Lowers Price Target to $9

RENB

Renovaro shares are trading higher after the company announced a merger agreement with BioSymetrics to advance AI-driven biomarket discovery and precision medicine.

<p>UBS  analyst Kevin Caliendo   maintains Henry Schein (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSIC#NASDAQ">HSIC</a>) with a Neutral and lowers the price target from $83 to $80.</p>


HSIC

UBS Maintains Neutral on Henry Schein, Lowers Price Target to $80

<p>Silo Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILO#NASDAQ">SILO</a>) ("Silo" or the "Company"), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced that the U.S. Patent and Trademark Office (USPTO) issued an Issue Notification for our previously filed patent application (No. 17/954,864) titled "Pharmacological Prophylactics Against Stress-Induced Affective Disorders in Females."&nbsp; The projected patent number is 12,239,614 and the issue date of such patent will be March 4, 2025.</p>
<p>The patent reinforces protection for Silo's lead asset, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD). The patent includes newly added claims to U.S. Patent 11,491,120, which was issued to Silo in November 2022.</p>


Biotech

General

SILO

Silo Pharma Granted U.S. Patent For Novel Intranasal Post-Traumatic Stress Disorder Treatment Titled "Pharmacological Prophylactics Against Stress-Induced Affective Disorders In Females"

<p>UBS  analyst Leonardo Olmos   maintains Globant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) with a Neutral and lowers the price target from $217 to $190.</p>


GLOB

UBS Maintains Neutral on Globant, Lowers Price Target to $190

<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.</p>
<ul>
<li>JP Morgan analyst Brian Essex upgraded<strong> Check Point Software Technologies Lt</strong>d. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHKP#NASDAQ">CHKP</a>) from Neutral to Overweight and raised the price target from $221 to $255. Check Point shares closed at $218.63 on Tuesday. <a href="https://www.benzinga.com/quote/CHKP/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Loop Capital analyst Timothy Greaves upgraded the rating for <strong>Porch Group, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRCH#NASDAQ">PRCH</a>) from Hold to Buy and announced a $6 price target. Porch Group shares closed at $3.79 on Tuesday. <a href="https://www.benzinga.com/quote/PRCH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler analyst Brent Bracelin upgraded <strong>ZoomInfo Technologies Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZI#NASDAQ">ZI</a>) from Underweight to Neutral and raised the price target from $10 to $11. ZoomInfo shares closed at $9.53 on Tuesday. <a href="https://www.benzinga.com/quote/ZI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley analyst Keith Weiss upgraded the rating for <strong>Intuit Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) from Equal-Weight to Overweight and maintained the price target of $730. Intuit shares closed at $555.63 on Tuesday. <a href="https://www.benzinga.com/quote/INTU/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Michael Rollins upgraded <strong>Lumen Technologies, In</strong>c. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUMN#NYSE">LUMN</a>) from Neutral to Buy and lowered the price target from $8 to $6.5. Lumen Technologies shares closed at $4.44 on Tuesday. <a href="https://www.benzinga.com/quote/LUMN/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
<p>Considering buying INTU stock? Here&#8217;s what analysts think: </p>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="578" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/26133224/image-229-1024x578.png" alt="" class="wp-image-800081" style="width:340px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/26133224/image-229-1024x578.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/26133224/image-229-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/26133224/image-229-768x433.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/26133224/image-229.png 1102w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p><strong>Read This Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43981181/nvidia-gears-up-for-q4-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts">Nvidia Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></strong></li>
</ul>


Upgrades

CHKP

LUMN

PRCH

This Intuit Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

<p>UBS  analyst Jon Windham   maintains First Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) with a Buy and lowers the price target from $360 to $285.</p>


FSLR

UBS Maintains Buy on First Solar, Lowers Price Target to $285

Renovaro And BioSymetrics Announce Definitive Merger Agreement To Advance AI-Driven Biomarker Discovery And Precision Medicine; No Financial Terms Disclosed

<p>UBS  analyst Andrea Alfonso   maintains Elanco Animal Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELAN#NYSE">ELAN</a>) with a Buy and lowers the price target from $18 to $17.</p>


ELAN

UBS Maintains Buy on Elanco Animal Health, Lowers Price Target to $17

<p>Benzinga's options scanner has just identified more than 9 option transactions on Pinterest (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>), with a cumulative value of $1,232,498. Concurrently, our algorithms picked up 5 puts, worth a total of 1,024,270.</p>
<h3>Expected Price Movements</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $35.0 to $45.0 for Pinterest during the past quarter. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Pinterest's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Pinterest's whale activity within a strike price range from $35.0 to $45.0 in the last 30 days. </p>
<h3>Pinterest Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1740594658_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PINS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$7.0</td>
<td>$6.8</td>
<td>$6.85</td>
<td>$40.00</td>
<td>$650.7K</td>
<td>3.6K</td>
<td>1.0K</td>
</tr>
<tr>
<td>PINS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$1.16</td>
<td>$1.08</td>
<td>$1.16</td>
<td>$45.00</td>
<td>$115.8K</td>
<td>4.1K</td>
<td>1.0K</td>
</tr>
<tr>
<td>PINS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$8.2</td>
<td>$8.15</td>
<td>$8.15</td>
<td>$42.00</td>
<td>$113.2K</td>
<td>1.1K</td>
<td>139</td>
</tr>
<tr>
<td>PINS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$10.65</td>
<td>$10.5</td>
<td>$10.5</td>
<td>$45.00</td>
<td>$112.3K</td>
<td>466</td>
<td>207</td>
</tr>
<tr>
<td>PINS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$10.55</td>
<td>$10.4</td>
<td>$10.4</td>
<td>$45.00</td>
<td>$104.0K</td>
<td>466</td>
<td>100</td>
</tr>
</tbody>
</table>
</p>
<h3>About Pinterest</h3>
<p>Pinterest is a social media platform with a focus on product and idea discovery. Pinterest users, or pinners, can leverage the platform as they go about gathering ideas on topics such as home improvement, fashion, cooking, and travel. The company has more than 500 million monthly active users, two thirds of whom are female. Pinterest generates revenue by selling digital ads on its platform. While the platform's user base spans the globe, the vast majority of its revenue stems from ads shown to North American users.</p>
<p>After a thorough review of the options trading surrounding Pinterest, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Pinterest's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 3,384,765, the PINS's price is up by 1.45%, now at $37.14. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 62 days.</li>
</ul>
<h3>What The Experts Say On Pinterest</h3>
<p>Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $46.4.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Guggenheim persists with their Neutral rating on Pinterest, maintaining a target price of $39.<br />
&#x2A; Maintaining their stance, an analyst from Wells Fargo continues to hold a Overweight rating for Pinterest, targeting a price of $47.<br />
&#x2A; Maintaining their stance, an analyst from RBC Capital continues to hold a Outperform rating for Pinterest, targeting a price of $50.<br />
&#x2A; An analyst from Piper Sandler has revised its rating downward to Neutral, adjusting the price target to $41.<br />
&#x2A; An analyst from Benchmark upgraded its action to Buy with a price target of $55. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Pinterest with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


Options

PINS

Market Whales and Their Recent Bets on PINS Options

<p>Financial giants have made a conspicuous bullish move on Amazon.com. Our analysis of options history for Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) revealed 144 unusual trades.</p>
<p>Delving into the details, we found 45% of traders were bullish, while 38% showed bearish tendencies. Out of all the trades we spotted, 33 were puts, with a value of $2,139,966, and 111 were calls, valued at $10,575,206.</p>
<h3>What's The Price Target?</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $60.0 to $280.0 for Amazon.com over the recent three months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Amazon.com's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Amazon.com's significant trades, within a strike price range of $60.0 to $280.0, over the past month.</p>
<h3>Amazon.com Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1740594652_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$43.5</td>
<td>$43.45</td>
<td>$43.5</td>
<td>$205.00</td>
<td>$1.1M</td>
<td>446</td>
<td>1.0K</td>
</tr>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$22.95</td>
<td>$22.5</td>
<td>$22.7</td>
<td>$280.00</td>
<td>$908.0K</td>
<td>1.0K</td>
<td>402</td>
</tr>
<tr>
<td>AMZN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$13.8</td>
<td>$13.75</td>
<td>$13.75</td>
<td>$210.00</td>
<td>$181.5K</td>
<td>1.1K</td>
<td>254</td>
</tr>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$43.5</td>
<td>$43.35</td>
<td>$43.5</td>
<td>$205.00</td>
<td>$169.6K</td>
<td>446</td>
<td>118</td>
</tr>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$156.45</td>
<td>$155.85</td>
<td>$156.1</td>
<td>$60.00</td>
<td>$156.1K</td>
<td>786</td>
<td>10</td>
</tr>
</tbody>
</table>
</p>
<h3>About Amazon.com</h3>
<p>Amazon is the leading online retailer and marketplace for third party sellers. Retail related revenue represents approximately 75% of total, followed by Amazon Web Services' cloud computing, storage, database, and other offerings (15%), advertising services (5% to 10%), and other the remainder. International segments constitute 25% to 30% of Amazon's non-AWS sales, led by Germany, the United Kingdom, and Japan.</p>
<p>Having examined the options trading patterns of Amazon.com, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Present Market Standing of Amazon.com</h3>
<ul>
<li>With a volume of 24,039,700, the price of AMZN is up 1.12% at $215.19. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 62 days.</li>
</ul>
<h3>Professional Analyst Ratings for Amazon.com</h3>
<p>5 market experts have recently issued ratings for this stock, with a consensus target price of $260.4.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from JMP Securities persists with their Market Outperform rating on Amazon.com, maintaining a target price of $285.<br />
&#x2A; Maintaining their stance, an analyst from Goldman Sachs continues to hold a Buy rating for Amazon.com, targeting a price of $255.<br />
&#x2A; An analyst from Wedbush has revised its rating downward to Outperform, adjusting the price target to $280.<br />
&#x2A; An analyst from Telsey Advisory Group persists with their Outperform rating on Amazon.com, maintaining a target price of $275.<br />
&#x2A; An analyst from Wells Fargo has decided to maintain their Equal-Weight rating on Amazon.com, which currently sits at a price target of $207. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Amazon.com with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


AMZN

Amazon.com Unusual Options Activity

Press Releases

GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer

GoodRx Report Shows Millions at Risk as Endocrinologist Shortages Hit Nearly 70% of U.S. Counties

GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

WM Technology, Inc. Names Sarah Griffis Chief Technology Officer

GoodRx Unleashes "GoodRx for Pets," Simplifying Access and Reducing Costs for Pet Medications

GoodRx Offering Free Telehealth Appointments to Los Angeles Residents Affected by Wildfires

Scott Wagner Joins GoodRx Board of Directors

GoodRx Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference Call

GoodRx Appoints Christopher A. McGinnis as Chief Financial Officer

GoodRx Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity Threats

Comments

GoodRx Holdings

GoodRx Holdings (GDRX) Options

GoodRx Holdings (NASDAQ:GDRX) Stock, Chaîne d'Options

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL